Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
620.0000 -16.90 (-2.65%)
NSE Sep 26, 2025 11:52 AM
Volume: 477.1K
 

620.00
-2.65%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 17% YoY to | 388 crore, above I-direct estimate of | 372 crore, driven by a strong performance in the chemicals business from the development & manufacturing vertical and continued traction in the discovery vertical EBITDA margins declined 144 bps to 32.5% YoY (I-direct estimate: 33%) mainly due to higher employee and other expenses. EBITDA grew 12% YoY to | 126.1 crore (I-direct estimate: | 123 crore)...
Syngene International Ltd. is trading below all available SMAs
More from Syngene International Ltd.
Recommended